MDC medlab clinical limited
Add to My Watchlist 0.00% ! $6.60

From Cann Group's quarterly announcement today: To further...

  1. jcurve
    4,515 Posts.
    lightbulb Created with Sketch. 1604
    clock Created with Sketch.
    28/01/22
    08:54
    Post #: 59178824
    From Cann Group's quarterly announcement today:

    To further accelerate domestic sales of the Satipharm Gelpell capsules an agreement has been reached with MedLab Clinical Ltd (Medlab) to market these products direct to doctors. MedLab has an existing team of medical science liaison officers operating in Australia. The Satipharm capsules will be marketed with MedLab’s range of CBD sprays, representing a leading offering of advanced delivery CBD products on the market.
    MDC Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade copper identified at Nejo Gold Project, Ethiopia
right-arrow Created with Sketch.
NEWS Kameelburg Niobium and REE mineralisation extends to 1,350 Meters
right-arrow Created with Sketch.
NEWS Unemployment expectations correctly called today's 4.3% rate
right-arrow Created with Sketch.
NEWS High-Grade Gold Discovery Extends 75m North at 8 Mile Drill Hole
right-arrow Created with Sketch.
NEWS Update on exploration at Fosterville and Glenlogan
right-arrow Created with Sketch.
NEWS Watch Exclusive Interviews with ASX Leaders
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.